What is Texas Capital's earnings per share (EPS)?

Texas Capital (TCBI) reported diluted earnings per share of $6.79 for fiscal year 2025. This represents a 430.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Texas Capital Financials

TCBI

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Texas Capital (TCBI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TCBI FY2025 2026-04-23

Funding-cost normalization, not balance-sheet expansion, drove FY2025 as a large asset base finally produced stronger returns.

Assets rose from $28.4B in FY2023 to $31.5B in FY2025, yet asset growth did not automatically create earnings. ROA fell to 0.2% in FY2024 before rebounding to 1.1% in FY2025, pointing to a profitability reset on an already-large balance sheet rather than a growth-driven recovery.

Revenue moved from $1.73B to $1.77B between FY2024 and FY2025, so top-line growth was modest. But interest expense dropped from $828M to $743M, which helps explain why profit recovery was much sharper than revenue growth.

Leverage eased as long-term debt fell from $859M to $621M, so stronger returns were not achieved by layering on more borrowing. Physical reinvestment stayed minimal: FY2025 operating cash flow of $360M covered capex of just $12.6M, meaning funding and balance-sheet management matter more here than heavy fixed-asset spending.

Financial Health Signals

Financial Profile 40/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Texas Capital's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Texas Capital's revenue grew a modest 2.4% year-over-year to $1.8B. This slow but positive growth earns a score of 40/100.

Leverage

Texas Capital carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 99/100, indicating a strong balance sheet with room for future borrowing.

Cash Flow

Texas Capital converts 19.6% of revenue into free cash flow ($347.6M). This strong cash generation earns a score of 78/100.

Returns

Texas Capital generates a 9.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 25/100. This is up from 2.3% the prior year.

Piotroski F-Score Neutral

6/9

Texas Capital passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

1.09x

For every $1 of reported earnings, Texas Capital generates $1.09 in operating cash flow ($360.2M OCF vs $330.2M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.8B

YoY+2.4%

5Y CAGR+11.3%

10Y CAGR+11.4%

Texas Capital generated $1.8B in revenue in fiscal year 2025. This represents an increase of 2.4% from the prior year.

EBITDA

N/A

Net Income

$330.2M

YoY+326.1%

5Y CAGR+37.9%

10Y CAGR+8.6%

Texas Capital reported $330.2M in net income in fiscal year 2025. This represents an increase of 326.1% from the prior year.

EPS (Diluted)

$6.79

YoY+430.5%

5Y CAGR+43.4%

10Y CAGR+8.8%

Texas Capital earned $6.79 per diluted share (EPS) in fiscal year 2025. This represents an increase of 430.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$347.6M

YoY-16.3%

5Y CAGR-33.3%

10Y CAGR+18.5%

Texas Capital generated $347.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 16.3% from the prior year.

Cash & Debt

$2.1B

YoY-34.2%

5Y CAGR-25.6%

10Y CAGR+1.6%

Texas Capital held $2.1B in cash against $620.6M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

44M

YoY-4.0%

5Y CAGR-2.6%

Texas Capital had 44M shares outstanding in fiscal year 2025. This represents a decrease of 4.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

18.6%

YoY+14.2pp

5Y CAGR+12.3pp

10Y CAGR-5.4pp

Texas Capital's net profit margin was 18.6% in fiscal year 2025, showing the share of revenue converted to profit. This is up 14.2 percentage points from the prior year.

Return on Equity

9.1%

YoY+6.8pp

5Y CAGR+6.8pp

10Y CAGR+0.2pp

Texas Capital's ROE was 9.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 6.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$185.8M

YoY+128.0%

Texas Capital spent $185.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 128.0% from the prior year.

Capital Expenditures

$12.6M

YoY-80.6%

5Y CAGR+35.1%

10Y CAGR+9.6%

Texas Capital invested $12.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 80.6% from the prior year.

TCBI Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.8B+2.4%	$1.7B+6.1%	$1.6B+42.4%	$1.1B+30.5%	$876.5M-15.7%	$1.0B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$480.5M+3.0%	$466.6M+1.5%	$459.7M+5.7%	$434.9M+24.2%	$350.2M+2.8%	$340.5M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$743.1M-10.3%	$828.3M+15.7%	$715.8M+166.6%	$268.5M+149.2%	$107.7M-42.7%	$188.1M
Income Tax	$102.5M+246.7%	$29.6M-48.6%	$57.5M-42.1%	$99.3M+18.0%	$84.1M+227.8%	$25.7M
Net Income	$330.2M+326.1%	$77.5M-59.0%	$189.1M-43.1%	$332.5M+30.9%	$253.9M+283.1%	$66.3M
EPS (Diluted)	$6.79+430.5%	$1.28-63.8%	$3.54-42.7%	$6.18+34.3%	$4.60+310.7%	$1.12

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$419.1M-5.7%	$444.3M-3.5%	$460.6M+4.8%	$439.6M+2.9%	$427.3M-2.3%	$437.6M-3.3%	$452.5M+7.2%	$422.1M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$139.3M+28.0%	$108.9M-9.2%	$119.9M-0.2%	$120.2M-8.7%	$131.6M+34.5%	$97.9M-19.2%	$121.1M+1.9%	$118.8M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$164.4M-7.1%	$176.9M-6.3%	$188.8M+1.4%	$186.2M-2.7%	$191.3M-8.0%	$208.0M-2.1%	$212.4M+3.4%	$205.5M
Income Tax	$20.6M-34.8%	$31.6M-2.9%	$32.6M+31.0%	$24.9M+85.4%	$13.4M-40.4%	$22.5M+220.5%	-$18.7M-210.3%	$16.9M
Net Income	$73.8M-26.7%	$100.7M-4.3%	$105.2M+36.1%	$77.3M+64.4%	$47.0M-33.8%	$71.0M+215.8%	-$61.3M-247.2%	$41.7M
EPS (Diluted)	$1.56	N/A	$2.18+38.0%	$1.58+71.7%	$0.92	N/A	$-1.41-276.3%	$0.80

TCBI Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$31.5B+2.6%	$30.7B+8.4%	$28.4B-0.2%	$28.4B-18.2%	$34.7B-7.9%	$37.7B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$2.1B-34.2%	$3.2B-1.7%	$3.2B-35.3%	$5.0B-36.9%	$7.9B-13.7%	$9.2B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$1.5M0.0%	$1.5M0.0%	$1.5M0.0%	$1.5M-90.1%	$15.1M0.0%	$15.1M
Total Liabilities	$27.9B+2.0%	$27.4B+8.8%	$25.2B-0.8%	$25.4B-19.6%	$31.5B-9.6%	$34.9B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$620.6M-6.0%	$660.3M-23.1%	$859.1M-7.8%	$931.4M+0.3%	$928.7M+134.6%	$395.9M
Total Equity	$3.6B+7.8%	$3.4B+5.3%	$3.2B+4.7%	$3.1B-4.8%	$3.2B+11.8%	$2.9B
Retained Earnings	$2.8B+12.5%	$2.5B+2.5%	$2.4B+7.6%	$2.3B+16.2%	$1.9B+13.7%	$1.7B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$33.5B+6.2%	$31.5B-3.1%	$32.5B+1.9%	$31.9B+1.8%	$31.4B+2.1%	$30.7B-2.8%	$31.6B+5.9%	$29.9B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$3.0B+40.9%	$2.1B-31.5%	$3.1B+13.9%	$2.7B-29.3%	$3.8B+19.2%	$3.2B-23.9%	$4.2B+43.9%	$2.9B
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	$1.5M	N/A	N/A	N/A	$1.5M	N/A	N/A
Total Liabilities	$29.9B+7.1%	$27.9B-3.4%	$28.9B+1.6%	$28.4B+1.7%	$27.9B+2.1%	$27.4B-3.2%	$28.3B+6.0%	$26.7B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$878.3M+41.5%	$620.6M0.0%	$620.4M0.0%	$620.3M-6.1%	$660.5M0.0%	$660.3M0.0%	$660.2M0.0%	$660.0M
Total Equity	$3.6B-0.7%	$3.6B-0.2%	$3.6B+3.6%	$3.5B+2.3%	$3.4B+1.8%	$3.4B+0.4%	$3.4B+5.6%	$3.2B
Retained Earnings	$2.9B+2.5%	$2.8B+3.6%	$2.7B+3.9%	$2.6B+2.9%	$2.5B+1.7%	$2.5B+2.7%	$2.4B-2.6%	$2.5B

TCBI Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$360.2M-25.0%	$480.1M+28.5%	$373.7M+152.6%	$148.0M-77.5%	$657.3M-75.1%	$2.6B
Capital Expenditures	$12.6M-80.6%	$64.8M+295.8%	$16.4M+45.4%	$11.3M+173.1%	$4.1M+47.6%	$2.8M
Free Cash Flow	$347.6M-16.3%	$415.2M+16.2%	$357.4M+161.4%	$136.7M-79.1%	$653.2M-75.2%	$2.6B
Investing Cash Flow	-$1.9B+25.2%	-$2.5B-41.2%	-$1.8B-153.1%	$3.3B+168.4%	$1.2B+142.0%	-$2.9B
Financing Cash Flow	$404.3M-79.2%	$1.9B+601.4%	-$387.7M+93.9%	-$6.4B-102.9%	-$3.1B-162.1%	$5.1B
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$185.8M+128.0%	$81.5M-22.4%	$105.0M-8.9%	$115.3M	$0	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$87.5M-32.9%	$130.5M-21.5%	$166.3M+164.0%	$63.0M+17018.8%	$368K-98.0%	$18.2M-94.5%	$332.8M+900.2%	$33.3M
Capital Expenditures	$1.4M+497.9%	-$341K-106.9%	$5.0M-10.7%	$5.5M+129.5%	$2.4M-67.4%	$7.4M-51.2%	$15.2M-31.6%	$22.2M
Free Cash Flow	$86.2M-33.8%	$130.2M-19.3%	$161.3M+180.8%	$57.5M+2905.3%	-$2.0M-118.9%	$10.8M-96.6%	$317.6M+2769.3%	$11.1M
Investing Cash Flow	-$1.1B-3258.0%	$36.2M+114.7%	-$245.7M+84.8%	-$1.6B-6761.3%	-$23.6M+90.2%	-$240.2M+47.4%	-$456.4M+53.0%	-$971.5M
Financing Cash Flow	$1.9B+268.8%	-$1.1B-349.4%	$454.1M+1.9%	$445.7M-30.0%	$636.9M+181.6%	-$780.8M-155.7%	$1.4B+162.0%	$535.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$75.1M-40.7%	$126.6M+1689.4%	$7.1M-66.3%	$21.0M-32.6%	$31.2M+119915.4%	-$26K	$0-100.0%	$50.0M

TCBI Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	18.6%+14.2pp	4.5%-7.1pp	11.6%-17.5pp	29.1%+0.1pp	29.0%+22.6pp	6.4%
Return on Equity	9.1%+6.8pp	2.3%-3.6pp	5.9%-5.0pp	10.9%+3.0pp	7.9%+5.6pp	2.3%
Return on Assets	1.1%+0.8pp	0.3%-0.4pp	0.7%-0.5pp	1.2%+0.4pp	0.7%+0.5pp	0.2%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.17-0.0	0.20-0.1	0.27-0.0	0.30+0.0	0.29+0.2	0.14
FCF Margin	19.6%-4.4pp	24.0%+2.1pp	21.9%+10.0pp	11.9%-62.6pp	74.5%-179.2pp	253.7%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	17.6%-5.0pp	22.7%-0.2pp	22.8%+5.2pp	17.6%+6.6pp	11.0%-5.2pp	16.2%+29.8pp	-13.6%-23.4pp	9.9%
Return on Equity	2.1%-0.7pp	2.8%-0.1pp	2.9%+0.7pp	2.2%+0.8pp	1.4%-0.7pp	2.1%+3.9pp	-1.8%-3.1pp	1.3%
Return on Assets	0.2%-0.1pp	0.3%0.0pp	0.3%+0.1pp	0.2%+0.1pp	0.1%-0.1pp	0.2%+0.4pp	-0.2%-0.3pp	0.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	0.24+0.1	0.170.0	0.170.0	0.18-0.0	0.190.0	0.200.0	0.20-0.0	0.21
FCF Margin	20.6%-8.7pp	29.3%-5.7pp	35.0%+22.0pp	13.1%+13.6pp	-0.5%-2.9pp	2.5%-67.7pp	70.2%+67.6pp	2.6%

Similar Companies

International Bancshares IBOC

$4.4B

United Cmnty Bks Blairsvle Ga UCB

$3.8B

Renasant RNST

$3.6B

Fulton Financial FULT

$3.9B

Atlantic Un Bankshares Corp AUB

$5.2B

Frequently Asked Questions

What is Texas Capital's annual revenue?

Texas Capital (TCBI) reported $1.8B in total revenue for fiscal year 2025. This represents a 2.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Texas Capital's revenue growing?

Texas Capital (TCBI) revenue grew by 2.4% year-over-year, from $1.7B to $1.8B in fiscal year 2025.

Is Texas Capital profitable?

Yes, Texas Capital (TCBI) reported a net income of $330.2M in fiscal year 2025, with a net profit margin of 18.6%.

How much debt does Texas Capital have?

As of fiscal year 2025, Texas Capital (TCBI) had $2.1B in cash and equivalents against $620.6M in long-term debt.

What is Texas Capital's net profit margin?

Texas Capital (TCBI) had a net profit margin of 18.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Texas Capital's return on equity (ROE)?

Texas Capital (TCBI) has a return on equity of 9.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Texas Capital's free cash flow?

Texas Capital (TCBI) generated $347.6M in free cash flow during fiscal year 2025. This represents a -16.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Texas Capital's operating cash flow?

Texas Capital (TCBI) generated $360.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Texas Capital's total assets?

Texas Capital (TCBI) had $31.5B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Texas Capital's capital expenditures?

Texas Capital (TCBI) invested $12.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Texas Capital buy back shares?

Yes, Texas Capital (TCBI) spent $185.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Texas Capital have outstanding?

Texas Capital (TCBI) had 44M shares outstanding as of fiscal year 2025.

What is Texas Capital's debt-to-equity ratio?

Texas Capital (TCBI) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Texas Capital's return on assets (ROA)?

Texas Capital (TCBI) had a return on assets of 1.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Texas Capital's Piotroski F-Score?

Texas Capital (TCBI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Texas Capital's earnings high quality?

Texas Capital (TCBI) has an earnings quality ratio of 1.09x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Texas Capital?

Texas Capital (TCBI) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.